IPCALAB

IPCA Laboratories Limited

Pharmaceuticals

Share price

₹1,946

Market cap

₹49,366 Cr

1Y return

▲ 48%

A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.

Investors holding IPCA Laboratories Limited

HDFC Mutual Fund

Mutual Fund

9.54%

Kotak Mutual Fund

Mutual Fund

6.36%

DSP Mutual Fund

Mutual Fund

4.64%

SBI Life Insurance

Institution

3.69%

Nippon India Mutual Fund

Mutual Fund

2.79%

Axis Mutual Fund

Mutual Fund

1.94%

HDFC Life Insurance

Institution

1.39%

Edelweiss Mutual Fund

Mutual Fund

1.19%

Foreign Investor

1.14%

HSBC Mutual Fund

Mutual Fund

1.05%

Recent moves 9

Axis Mutual FundIncreased

Axis Mutual Fund increased its stake in IPCA Laboratories from 1.83% to 1.94%, buying 2,78,227 shares at ₹1920.40 apiece, for a total value of ₹53.43 Cr.

Edelweiss Mutual FundIncreased

Edelweiss Mutual Fund increased its stake in IPCA Laboratories Limited from 1.03% to 1.19%, raising its shareholding from 2,602,635 to 3,019,905 shares. This represents an increase of 417,270 shares.

Kotak OffshoreDecreased

Kotak Offshore reduced its stake in IPCA Laboratories from 1.19% to 1.14% by selling 114,115 shares. The value of the sold shares was approximately ₹21.9 Cr at ₹1920.40 apiece.

HDFC Life InsuranceDecreased

HDFC Life Insurance decreased its stake in IPCA Laboratories Limited from 1.56% to 1.39%, selling 429,112 shares. The value of the shares sold is ₹82.3 Cr at a price of ₹1920.40 apiece.

SBI Life InsuranceIncreased

SBI Life Insurance increased its stake in IPCA Laboratories Limited from 3.58% to 3.69% by purchasing 288,920 shares. The shares were valued at approximately ₹55.48 Cr based on a share price of ₹1920.40.

HSBC Mutual FundNew position

HSBC Mutual Fund entered IPCA Laboratories Limited with 26,76,396 shares, acquiring a 1.05% stake worth ₹48.71 Cr at ₹1823.30 apiece.

DSP Mutual FundDecreased

DSP Mutual Fund decreased its stake in IPCA Laboratories from 5.52% to 4.64% by selling 2,237,449 shares. The value of the sold shares is ₹429.69 crore at a price of ₹1920.40 apiece. This transaction takes DSP Mutual Fund below the 5% disclosure threshold.

Kotak Mutual FundIncreased

Kotak Mutual Fund increased its stake in IPCA Laboratories Limited from 6.28% to 6.36%, increasing its shareholding from 15,928,214 to 16,141,739 shares.

HDFC Mutual FundDecreased

HDFC Mutual Fund decreased its stake in Ipca Laboratories from 9.60% to 9.54% by selling 149,082 shares. The shares were valued at approximately ₹28.63 crore based on a share price of ₹1920.40.

Track the whales in IPCA Laboratories Limited

Get alerted the moment a top investor buys or sells.